Understanding antibodies after norovirus infection and vaccination
Antibody Landscape following Human Norovirus Infection and Vaccination
This study is looking at how our immune system fights off norovirus infections and vaccines by examining the antibodies we produce, and it's designed for anyone interested in how we can create better vaccines to protect against this pesky virus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10806942 on NIH RePORTER |
What this research studies
This research investigates how the human immune system responds to norovirus infections and vaccinations by analyzing the antibodies produced. It aims to identify the specific parts of the virus that trigger a protective immune response, which is crucial for developing effective vaccines. The study utilizes samples from individuals who have been vaccinated or infected to explore the mechanisms of immunity and how the virus can evade it. By understanding these processes, the research seeks to improve vaccine design against norovirus, particularly for the most common and dangerous strains.
Who could benefit from this research
Good fit: Ideal candidates for this research include infants, the elderly, and immunosuppressed individuals who are at higher risk for severe norovirus infections.
Not a fit: Patients who have not been exposed to norovirus or those who are not at risk for severe gastroenteritis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines against norovirus, reducing the incidence of severe gastroenteritis.
How similar studies have performed: Previous research has shown promise in understanding immune responses to viral infections, suggesting that this approach could yield valuable insights into norovirus immunity.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Baric, Ralph S — Univ of North Carolina Chapel Hill
- Study coordinator: Baric, Ralph S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.